HolderBook

TETRAPHASE PHARMACEUTICALS I (TTPH)

Institutional ownership reported to the SEC as of Q2 2020, across 7 quarters.

18
Reporting holders
$5.7M
Reported value
0.0%
Held as options
+0
Holder change

Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.

Holders

FilerValueShares Their book Held Change
ARMISTICE CAPITAL, LLC$3.6M1,419,5070.16%3qHELD
RENAISSANCE TECHNOLOGIES LLC$552.0K219,1400.00%4q-8.7%-$52.4K
CVI Holdings, LLC$524.0K208,0740.19%2qHELD
ACADIAN ASSET MANAGEMENT LLC$197.0K78,2180.00%newNEW
VANGUARD GROUP INC$175.0K69,4020.00%4q+72.6%+$73.6K
GEODE CAPITAL MANAGEMENT, LLC$161.0K64,0920.00%4q+53.6%+$56.2K
BlackRock Inc.$138.0K54,7210.00%4q-21.6%-$38.0K
Tekla Capital Management LLC$108.0K42,9650.00%4qHELD
BRIDGEWAY CAPITAL MANAGEMENT INC$76.0K30,0000.00%2qHELD
Bank of New York Mellon Corp$58.0K23,1170.00%2q-17.9%-$12.6K
BANK OF AMERICA CORP /DE/$37.0K14,6950.00%4q+34.3%+$9.5K
DIMENSIONAL FUND ADVISORS LP$32.0K12,6640.00%4q-16.3%-$6.2K
NORTHERN TRUST CORP$25.0K10,0430.00%newNEW
JPMORGAN CHASE & CO$13.0K5,0690.00%newNEW
UBS Group AG$7.0K2,9250.00%4qHELD
Sargent Bickham Lagudis LLC$3.0K1,0000.00%newNEW
GROUP ONE TRADING, L.P.$2.0K6010.00%4qHELD
MORGAN STANLEY$1.0K3220.00%newNEW

Quarter by quarter

Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.

QuarterHoldersValue SharesNewAdded TrimmedOptions
Q2 202018$5.7M2,256,5555340.0%
Q1 202018$3.9M3,070,5557620.0%
Q4 201918$2.0M722,5834660.0%
Q3 201922$2.7M503,07322000.0%
Q2 20191$4.0K0000100.0%
Q1 20192$120.0K0000100.0%
Q4 20182$44.0K0000100.0%